| Dr David Dante Pellei, | |
|
1701 East Blvd, Charlotte, NC 28203-5823 | |
| (704) 334-7800 | |
| (704) 334-7818 |
| Full Name | Dr David Dante Pellei |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 29 Years |
| Location | 1701 East Blvd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427057934 | NPI | - | NPPES |
| 89126JX | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Augusta Health | Fishersville, VA | Hospital |
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bath County Community Hospital | 0840193819 | 24 |
| Augusta Health Care Inc | 1355248212 | 46 |
| Augusta Medical Group | 3678632544 | 320 |
| Radiology Associates Of Richmond Inc | 9830088434 | 72 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
National Mentor Holdings, announced today that it has priced an offering of $250 million in aggregate principal amount of 12.50% senior notes due 2018 through a private offering that is exempt from registration under the Securities Act of 1933, as amended.
Scientists in Iran have found that electronic mosquito repellents which are marketed as being able to drive insects away with high-pitched sounds do not work.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 2 days ago
| Entity Name | Bath County Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417989278 PECOS PAC ID: 0840193819 Enrollment ID: O20040128000523 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
National Mentor Holdings, announced today that it has priced an offering of $250 million in aggregate principal amount of 12.50% senior notes due 2018 through a private offering that is exempt from registration under the Securities Act of 1933, as amended.
Scientists in Iran have found that electronic mosquito repellents which are marketed as being able to drive insects away with high-pitched sounds do not work.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 2 days ago
| Entity Name | Radiology Associates Of Richmond Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447297577 PECOS PAC ID: 9830088434 Enrollment ID: O20040312000021 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
National Mentor Holdings, announced today that it has priced an offering of $250 million in aggregate principal amount of 12.50% senior notes due 2018 through a private offering that is exempt from registration under the Securities Act of 1933, as amended.
Scientists in Iran have found that electronic mosquito repellents which are marketed as being able to drive insects away with high-pitched sounds do not work.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 2 days ago
| Entity Name | Tidewater Diagnostic Imaging Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073626396 PECOS PAC ID: 2769463702 Enrollment ID: O20040526000855 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
National Mentor Holdings, announced today that it has priced an offering of $250 million in aggregate principal amount of 12.50% senior notes due 2018 through a private offering that is exempt from registration under the Securities Act of 1933, as amended.
Scientists in Iran have found that electronic mosquito repellents which are marketed as being able to drive insects away with high-pitched sounds do not work.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 2 days ago
| Entity Name | Augusta Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245489590 PECOS PAC ID: 3678632544 Enrollment ID: O20081106000590 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
National Mentor Holdings, announced today that it has priced an offering of $250 million in aggregate principal amount of 12.50% senior notes due 2018 through a private offering that is exempt from registration under the Securities Act of 1933, as amended.
Scientists in Iran have found that electronic mosquito repellents which are marketed as being able to drive insects away with high-pitched sounds do not work.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 2 days ago
| Entity Name | Augusta Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720717044 PECOS PAC ID: 1355248212 Enrollment ID: O20221229000080 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
National Mentor Holdings, announced today that it has priced an offering of $250 million in aggregate principal amount of 12.50% senior notes due 2018 through a private offering that is exempt from registration under the Securities Act of 1933, as amended.
Scientists in Iran have found that electronic mosquito repellents which are marketed as being able to drive insects away with high-pitched sounds do not work.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Dante Pellei, 1701 East Blvd, Charlotte, NC 28203-5823 Ph: (704) 334-7800 | Dr David Dante Pellei, 1701 East Blvd, Charlotte, NC 28203-5823 Ph: (704) 334-7800 |
News Archive
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
National Mentor Holdings, announced today that it has priced an offering of $250 million in aggregate principal amount of 12.50% senior notes due 2018 through a private offering that is exempt from registration under the Securities Act of 1933, as amended.
Scientists in Iran have found that electronic mosquito repellents which are marketed as being able to drive insects away with high-pitched sounds do not work.
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 2 days ago
Whitney Feltus, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 980-208-1704 Fax: 704-926-1832 | |
Edward Barnwell Black, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1705 East Blvd, Charlotte, NC 28203 Phone: 704-909-5960 Fax: 704-770-0501 | |
Thaddeus Drexel Houston, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1701 East Blvd, Charlotte, NC 28203 Phone: 704-334-7800 Fax: 704-414-7512 | |
Matthew James Locker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 704-332-1291 Fax: 704-926-1832 | |
Kelli A. Reardon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 Queens Rd, Charlotte, NC 28204 Phone: 434-982-0777 Fax: 434-982-0792 | |
Mr. Andrew Joseph Bojanowski, PA-C Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr Ste 216, Charlotte, NC 28211 Phone: 704-332-1291 | |
Dr. John William Black, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3623 Latrobe Dr, Suite 216, Charlotte, NC 28211 Phone: 704-332-1291 Fax: 704-332-5206 |